FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Padagis US Gynazole-1 Recall

Gynazole-1, (Butoconazole Nitrate) Vaginal Cream USP, 2%

Padagis US LLC · Minneapolis, MN

Risk level
Class II
Reported by FDA
Nov 8, 2023
Recall ID
D-0081-2024
Check your lot numberHow we source this data

Summary

Padagis US recalled Gynazole-1 starting Sep 28, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0081-2024 on Nov 8, 2023. Reason: Incorrect Product Formulation: Hydrophilic Colloidal Silica was used to manufacture the product rather than Hydrophobic Colloidal Silica as required by the manufacturing process. Status: Ongoing.

Why it was recalled

Incorrect Product Formulation: Hydrophilic Colloidal Silica was used to manufacture the product rather than Hydrophobic Colloidal Silica as required by the manufacturing process.

Product description

Gynazole-1, (Butoconazole Nitrate) Vaginal Cream USP, 2%, Net Wt 5.8 g per pre-filled applicator, packaged in 1 prefilled applicator per carton, Rx Only, Manufactured By Padagis, Yeruham, Israel; Distributed By: Padagis, Allegan, MI 49010. NDC: 45802-396-01

Lot numbers, UPCs & expiration codes

Lot#: 164185, Exp. Date 4/2024

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0081-2024
Classification
Class II
Status
Ongoing
Recall initiated
Sep 28, 2023
FDA report date
Nov 8, 2023
Quantity
10,512 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Padagis US LLC

Original FDA data

Every field from FDA enforcement report D-0081-2024, exactly as published.

Show all FDA fields
City
Minneapolis
State
MN
Status
Ongoing
Country
United States
Event ID
93189
Address
3940 Quebec Ave N
Code information
Lot#: 164185, Exp. Date 4/2024
Postal code
55427-1244
Report date
Nov 8, 2023
Product type
Drugs
Recall number
D-0081-2024
Classification
Class II
Recalling firm
Padagis US LLC
Product quantity
10,512 cartons
Reason for recall
Incorrect Product Formulation: Hydrophilic Colloidal Silica was used to manufacture the product rather than Hydrophobic Colloidal Silica as required by the manufacturing process.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Gynazole-1, (Butoconazole Nitrate) Vaginal Cream USP, 2%, Net Wt 5.8 g per pre-filled applicator, packaged in 1 prefilled applicator per carton, Rx Only, Manufactured By Padagis, Yeruham, Israel; Distributed By: Padagis, Allegan, MI 49010. NDC: 45802-396-01
Distribution pattern
Nationwide within the United States
Recall initiation date
Sep 28, 2023
Initial firm notification
Letter
Center classification date
Oct 31, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0081-2024, published Nov 8, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls